BioSpace News Archive

The U.S. Food and Drug Administration (FDA) Priority Review for capmatinib is based on Phase 2 data in first-line and previously treated patients with MET exon 14 skipping (METex14) mutated advanced non-small cell lung cancer (NSCLC)

New investor Fountain Healthcare Partners provides a further €5 M capital increase adding on the initial €39 M announced last September.

MEDICREA®, pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD® ASI proprietary software platform, concierge expert services and technologies, announced that it has received FDA-Clearance for UNiD® IB3D Patient-Matched interbody cages which completes its UNiD® ASI platform technology.

Medivir AB invites investors, analysts and the media to an R&D Day in Stockholm, Monday March 2, 2020, at 14:00 to 16:30 CET.

Vakrangee announces alliance with vHealth by Aetna, a Digital Primary Healthcare service for rural India

The Virtual Care Task Force, a collaboration of the Canadian Medical Association, the Royal College of Physicians and Surgeons of Canada and the College of Family Physicians of Canada, released its recommendations for enabling and expanding the implementation of virtual care in Canada.

Dallas-based healthcare AI startup DocSynk is pleased to announce bridge funding from Chicago-based PE firm Colosseum Group.

TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need in pain management, ophthalmology and oncology, announced financial results for the fiscal year ended December 31, 2019, and provided a business update.